Vivos (RDGL) FCF Margin Growth (1y) (2011 - 2025)
Vivos (RDGL) FCF Margin Growth (1y) (2011 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn | 194.00 |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn | 66.00 |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn | -192.00 |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn | 119.00 |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn | 1,788.00 |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | -395.00 |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn | 112.00 |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn | -505.00 |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn | -473.00 |
| 10 | Vivos | 24.08 Mn | 22.53 Mn | -3,105.00 | 724,783.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 724,783.00 |
| Sep 30, 2025 | -1.43 Mn |
| Jun 30, 2025 | -139,739.00 |
| Mar 31, 2025 | 610,838.00 |
| Sep 30, 2024 | -695,481.00 |
| Jun 30, 2024 | 220,329.00 |
| Mar 31, 2024 | -291,643.00 |
| Sep 30, 2023 | 118,312.00 |
| Jun 30, 2023 | -320,626.00 |
| Mar 31, 2023 | -193,761.00 |
| Sep 30, 2022 | -315,725.00 |
| Sep 30, 2021 | 143,124.00 |
| Sep 30, 2020 | -31,539.00 |
| Mar 31, 2017 | 726,189.00 |
| Sep 30, 2016 | 7.83 Mn |
| Mar 31, 2016 | -1.19 Mn |
| Mar 31, 2015 | 85,950.00 |
| Mar 31, 2014 | -82,251.00 |
| Sep 30, 2013 | 68,063.00 |
| Mar 31, 2013 | -180,528.00 |